New Relic Statistics
Total Valuation
Novartis AG has a market cap or net worth of ARS 301.92 trillion. The enterprise value is 336.12 trillion.
Market Cap | 301.92T |
Enterprise Value | 336.12T |
Important Dates
The last earnings date was Thursday, July 17, 2025.
Earnings Date | Jul 17, 2025 |
Ex-Dividend Date | Mar 12, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -3.37% |
Shares Change (QoQ) | -0.96% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.84B |
Valuation Ratios
The trailing PE ratio is 18.56 and the forward PE ratio is 13.59.
PE Ratio | 18.56 |
Forward PE | 13.59 |
PS Ratio | 4.59 |
PB Ratio | 6.02 |
P/TBV Ratio | n/a |
P/FCF Ratio | 13.11 |
P/OCF Ratio | 12.19 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.72, with an EV/FCF ratio of 14.60.
EV / Earnings | 20.66 |
EV / Sales | 4.63 |
EV / EBITDA | 10.72 |
EV / EBIT | 13.32 |
EV / FCF | 14.60 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.
Current Ratio | 0.82 |
Quick Ratio | 0.50 |
Debt / Equity | 0.78 |
Debt / EBITDA | 1.37 |
Debt / FCF | 1.69 |
Interest Coverage | 17.47 |
Financial Efficiency
Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 16.47%.
Return on Equity (ROE) | 32.49% |
Return on Assets (ROA) | 11.88% |
Return on Invested Capital (ROIC) | 16.47% |
Return on Capital Employed (ROCE) | 26.39% |
Revenue Per Employee | 866.67M |
Profits Per Employee | 214.43M |
Employee Count | 75,883 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Novartis AG has paid 2.35 trillion in taxes.
Income Tax | 2.35T |
Effective Tax Rate | 12.62% |
Stock Price Statistics
The stock price has increased by +7.35% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +7.35% |
50-Day Moving Average | 36,109.50 |
200-Day Moving Average | 32,915.13 |
Relative Strength Index (RSI) | 64.20 |
Average Volume (20 Days) | 401 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of ARS 65.77 trillion and earned 16.27 trillion in profits. Earnings per share was 8,163.07.
Revenue | 65.77T |
Gross Profit | 50.17T |
Operating Income | 22.86T |
Pretax Income | 18.60T |
Net Income | 16.27T |
EBITDA | 28.07T |
EBIT | 22.86T |
Earnings Per Share (EPS) | 8,163.07 |
Balance Sheet
The company has 8.02 trillion in cash and 38.89 trillion in debt, giving a net cash position of -30,870.99 billion.
Cash & Cash Equivalents | 8.02T |
Total Debt | 38.89T |
Net Cash | -30,870.99B |
Net Cash Per Share | n/a |
Equity (Book Value) | 50.12T |
Book Value Per Share | 25,845.72 |
Working Capital | -6,882.07B |
Cash Flow
In the last 12 months, operating cash flow was 24.77 trillion and capital expenditures -1,744.65 billion, giving a free cash flow of 23.03 trillion.
Operating Cash Flow | 24.77T |
Capital Expenditures | -1,744.65B |
Free Cash Flow | 23.03T |
FCF Per Share | n/a |
Margins
Gross margin is 76.28%, with operating and profit margins of 34.76% and 24.74%.
Gross Margin | 76.28% |
Operating Margin | 34.76% |
Pretax Margin | 28.28% |
Profit Margin | 24.74% |
EBITDA Margin | 42.68% |
EBIT Margin | 34.76% |
FCF Margin | 35.02% |
Dividends & Yields
This stock pays an annual dividend of 624.65, which amounts to a dividend yield of 1.65%.
Dividend Per Share | 624.65 |
Dividend Yield | 1.65% |
Dividend Growth (YoY) | 34.57% |
Years of Dividend Growth | 2 |
Payout Ratio | 57.26% |
Buyback Yield | 3.37% |
Shareholder Yield | 5.01% |
Earnings Yield | 5.39% |
FCF Yield | 7.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.
Last Split Date | Oct 22, 2020 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Novartis AG has an Altman Z-Score of 3.73 and a Piotroski F-Score of 6.
Altman Z-Score | 3.73 |
Piotroski F-Score | 6 |